Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0220
-0.0035
(-13.73%)
At close: April 4 at 8:14:07 AM GMT+2
Loading Chart for UUDA.SG
- Previous Close
0.0255 - Open
0.0220 - Bid 0.0215 x --
- Ask 0.0380 x --
- Day's Range
0.0220 - 0.0220 - 52 Week Range
0.0065 - 0.0560 - Volume
0 - Avg. Volume
5,846 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: UUDA.SG
View MorePerformance Overview: UUDA.SG
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
UUDA.SG
42.86%
S&P/ASX 200 [XJO] (^AXJO)
6.02%
1-Year Return
UUDA.SG
158.82%
S&P/ASX 200 [XJO] (^AXJO)
1.36%
3-Year Return
UUDA.SG
61.74%
S&P/ASX 200 [XJO] (^AXJO)
2.05%
5-Year Return
UUDA.SG
57.69%
S&P/ASX 200 [XJO] (^AXJO)
51.31%
Compare To: UUDA.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
4.6800
-22.64%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.1400
+0.94%
Mkt Cap EUR 5.386B
Industry Medical Distribution
17.20
-4.44%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
17.90
-6.77%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2900
+0.69%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
23.80
+0.85%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.5076
0.00%
Mkt Cap 57.185M
Industry Drug Manufacturers—Specialty & Generic
0.0040
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: UUDA.SG
View MoreValuation Measures
As of 4/4/2025
Market Cap
52.07M
Enterprise Value
41.82M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.38
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--